30 January 2015 – The next MPAC meeting will take place on 5–7 March. The Committee will assess the cost-effectiveness and potential future role of the RTS,S malaria vaccine candidate, discuss the role of G6PD testing in anti-relapse therapy for P. Vivax malaria, and hear an update from the Vector Control Advisory Group. The agenda also includes a discussion on the elimination strategy for the Greater Mekong subregion, and a number of other technical items. The first two days of the meeting are open to the public but advance registration is required.
WHO observes emergency MDA campaign for malaria in Sierra Leone
22 January 2015 – Experts from the WHO Global Malaria Programme were in Sierra Leone this week, working on a preliminary assessment of two recent mass drug administration campaigns for malaria which aimed to reduce the number of fever cases that might be mistaken for Ebola. The two successive emergency MDA campaigns reached more than 2.5 million people in Ebola-affected areas. The campaign was implemented by the National Malaria Control Programme, in collaboration with Médecins Sans Frontières, UNICEF and other partners, with technical support and guidance by WHO.
13 January 2015 – The WHO Global Malaria Programme and the Global Health Group at the University of California are collaborating on a series of case studies on malaria elimination. The latest report reviews how the Island of Reunion had eliminated the disease by the end of the 1970s and how it has successfully prevented its re-establishment since. Previous reports in the series have documented the malaria elimination process in Cabo Verde, Mauritius, Sri Lanka, Turkey and Turkmenistan. The production of the series is being supported by the Bill & Melinda Gates Foundation. The Reunion case study is available in both English and French.